Kidney Transplant Infection

• CLINICAL_TRIALS trial_result · 2024-04-05
  Clinical Trial Update: Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study [Phase 4]

  A Phase 4 pilot study evaluated quinolone prophylaxis to prevent BK virus infection in kidney transplant recipients; results completed and p…

• CLINICAL_TRIALS trial_result · 2023-07-27
  Clinical Trial Update: Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection [Phase 2]

  Phase 2 trial suggesting conversion to Envarsus post-kidney transplant may reduce BK infection risk.

• CLINICAL_TRIALS trial_result · 2023-03-24
  Clinical Trial Update: Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients. [Phase 4]

  Phase 4 clinical trial evaluating a food supplement for preventing urinary tract infections in kidney transplant patients has completed.

• CLINICAL_TRIALS trial_result · 2021-07-16
  Clinical Trial Update: A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus [Phase 3]

  Phase 3 trial comparing brincidofovir to valganciclovir for prevention of cytomegalovirus in transplant patients; study terminated with post…

• CLINICAL_TRIALS trial_result · 2021-06-07
  Clinical Trial Update: Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring. [Phase 2]

  Phase 2 clinical trial investigating γδ T cell immunomonitoring for secondary prophylaxis of CMV disease in kidney transplant patients has c…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-03-16
  Clinical Trial Update: Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation [Phase 4]

  Phase 4 trial update on grazoprevir/elbasvir for genotype 1b chronic hepatitis C after liver or kidney transplantation; study terminated.

• CLINICAL_TRIALS trial_result · 2021-02-02
  Clinical Trial Update: Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin. [Phase 3]

  Phase 3 randomized trial evaluating valganciclovir prophylaxis in CMV-seropositive kidney transplant patients to influence thymoglobulin-ind…

• CLINICAL_TRIALS trial_result · 2019-07-12
  Clinical Trial Update: Transplantation Using Hepatitis C Positive Donors, A Safety Trial [Phase 3]

  Phase 3 safety trial exploring transplantation using hepatitis C positive donors; results and status are unknown.